Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03172143 · ClinicalTrials.gov registry record · NA
Mesenteric Sparing for the Prevention of Recurrent Crohn's Disease
A NA study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT03172143: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT03172143 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03172143, a NA study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if taking an increased sampling of mesentery (fatty tissue next to the intestine) and lymph nodes at the time of the subject's ileocolic resection prevents a 4-6 month recurrence of Crohn's disease at the site of the new connection.
Interventions
- PROCEDURE Mesenteric Sparing Ileocolic Resection
- PROCEDURE High Ligation Ileocolic Resection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2017-08-29 |
| Est. Completion | 2018-12-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03172143
The ClinicalTrials.gov registry entry for NCT03172143 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Mesenteric Sparing Ileocolic Resection is the first listed.
NCT03172143 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03172143 about?
NCT03172143 is a clinical study titled "Mesenteric Sparing for the Prevention of Recurrent Crohn's Disease". The purpose of this study is to determine if taking an increased sampling of mesentery (fatty tissue next to the intestine) and lymph nodes at the time of the subject's ileocolic resection prevents a 4-6 month recurrence of Crohn's disease at the site of the new connection.
What is the current status of trial NCT03172143?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2017-08-29. Estimated completion is 2018-12-18.
What interventions are being tested in trial NCT03172143?
The interventions under investigation include: Mesenteric Sparing Ileocolic Resection (PROCEDURE), High Ligation Ileocolic Resection (PROCEDURE).
Who is sponsoring clinical trial NCT03172143?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.